Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified Health Condition 2: J452- Mild intermittent asthma Health Condition 3: J453- Mild persistent asthma Health Condition 4: J454- Moderate persistent asthma Health Condition 5: J459- Other and unspecified asthma Health Condition 6: J455- Severe persistent asthma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria for patients with COPD: (1) Men and women aged (2) Resident of Chandigarh Tricity or Ambala district; (3) Have basic digital literacy and have access to Android smart phones with internet connection; (4) Can read and write English, Hindi or Punjabi; (5) Consent to participate in the study. Inclusion criteria for patients with asthma: (1) Age 18-65 years and both sex with bronchial asthma; (2) Resident of Chandigarh Tricity or Ambala district; (3) Can read and write English, Hindi or Punjabi and have basic digital literacy; (4) Have access to Android smart phones with internet connection; (5) Ready to give written consent to participate in the study.
Exclusion criteria
Exclusion criteria: Exclusion criteria for patients with COPD: (1) Patients with coexisting non-COPD pulmonary conditions (e.g., lung cancer, sarcoidosis, and others); (2) Prior lung-volume reduction surgery and/or lung transplant; (3) Long-term supplemental oxygen >=12h/day; (4) >6 weeks of oral corticosteroids; (5) Serious or uncontrolled comorbidities likely to interfere with the study. Exclusion criteria for patients with asthma: (1) Severe refractory asthma (defined as difficult to control asthma i.e., on high intensity treatment and uncontrolled asthma despite good adherence (>=80% of prescribed inhaled corticosteroids) to prescription and good inhalation technique); (2) Presence of any active lung disease other than asthma (e.g., COPD, lung cancer, sarcoidosis, active tuberculosis, chronic pulmonary aspergillosis, bronchiectasis, allergic broncho-pulmonary aspergillosis, interstitial lung disease) or underwent lung reduction or related surgical interventions; (3) Long-term supplemental oxygen or home NIV as these patients generally have end-stage lung disease and may not respond to our interventions; (4) Mental impairment or language difficulties that make informed consent impossible.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life (Asthma-related or health-related for COPD)Timepoint: 3, 6, and 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Knowledge, attitude and self-efficacy practices, medication adherence, six-minute walk test, Asthma disease control (for asthma patients), Oral health status, Self-reported smoking cessation, Cost-effectiveness, Acute exacerbations, hospital visits and hospital admissions, Patientâ??s satisfaction and perspectives about the barriers and facilitators of the intervention.Timepoint: 3, 6, and 12 months | — |
Countries
India
Contacts
Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh